Clinical trial
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With…
NCT00026403 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00026403 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer |
| Official title | A Phase II Study of Gemcitabine, Cisplatin and Radiation Therapy in Patients With Locally Advanced Pancreatic Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Radiation |
| Interventions | cisplatin, gemcitabine hydrochloride, radiation therapy |
| Enrollment | 48 |
| Start date | Sep 1, 2001 |
| Primary completion | Jun 1, 2007 |
| Completion | Jul 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 14, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: